| 1 |
Donald J. Barnickel |
AT&T |
10 |
| 2 |
Maud Urbanski |
Johnson & Johnson |
7 |
| 3 |
Machteld M. Mertens |
ExxonMobil |
4 |
| 3 |
Lawrence W. Thau, Jr. |
Victaulic |
4 |
| 3 |
Gregory Szewczyk |
Colgate-Palmolive |
4 |
| 3 |
Christopher W. Boyce |
Merck |
4 |
| #7 |
Jeffrey M. Cogen |
Dow Global Technologies |
3 |
| #7 |
Daniel P. Leta |
ExxonMobil |
3 |
| #7 |
Sean C. Ely |
Ingersoll-Rand |
3 |
| #7 |
Kevin Cooper |
Agency For Science, Technology And Research |
3 |
| #11 |
Arthur Weber |
— |
2 |
| #11 |
Bahman Barazesh |
Agere Systems |
2 |
| #11 |
Frank J. Beitz |
Dyna-Tech Sales |
2 |
| #11 |
Ben Silber |
Globus Medical |
2 |
| #11 |
Joseph Zavatsky |
Johnson & Johnson |
2 |
| #11 |
Rostam Madon |
Basf Se |
2 |
| #11 |
Anthony S. Mennito |
ExxonMobil |
2 |
| #11 |
Rostam Jal Madon |
Basf Se |
2 |
| #11 |
Christopher T. Wagner |
Lifecell |
2 |
| #11 |
Wu Suen |
Henkel Ip & Holding Gmbh |
2 |
| #11 |
Daniel J. Taylor |
Microsoft |
2 |
| #11 |
Martin Jeffrey Abbott |
Cellco Partnership |
2 |
| #11 |
Mallikarjun Sundaram |
Momenta Pharmaceuticals |
2 |
| #11 |
Atul Thaper |
Verizon |
2 |
| #11 |
James E. Gillberg |
Fairchild Semiconductor |
2 |
| #11 |
Panna Dutta |
Chiesi Farmaceutici S.P.A. |
2 |
| #11 |
James M. Brown |
Bigfix |
2 |
| #11 |
Christopher G. Levins |
Johnson & Johnson |
2 |
| #11 |
Scott Beers |
Comcast |
2 |
| #11 |
Stephen T. Wrobleski |
Bristol-Myers Squibb |
2 |
| #11 |
Kenneth Smith |
Solidia Technologies |
2 |
| #11 |
M. Dalil Rahman |
Clariant Finance (Bvi) Limited |
2 |
| #11 |
Gregory J. DeMartin |
ExxonMobil |
2 |
| #11 |
David T. Ferrughelli |
ExxonMobil |
2 |
| #11 |
Kenneth P. Glynn |
Ideal Ideas |
2 |
| #11 |
Joseph Gunnet |
Chromocell |
2 |
| #37 |
Robert W. Van Holten |
Johnson & Johnson |
1 |
| #37 |
Cynthia L. Cain |
Henkel Ip & Holding Gmbh |
1 |
| #37 |
Ricky Bennett |
Dek Printing Machines |
1 |
| #37 |
Dan V. Goia |
Umicore Ag & Co. Kg |
1 |
| #37 |
Peter Wisniewski |
Colgate-Palmolive |
1 |
| #37 |
Russell L. Kreeger |
Union Carbide |
1 |
| #37 |
Ira J. Pitel |
Ion Systems |
1 |
| #37 |
Philip DiParisi |
Thomas & Betts International |
1 |
| #37 |
Kevin Mulcahy |
Tata Consultancy Services Limited |
1 |
| #37 |
Susan Bonitz |
Accentia Biopharmaceuticals |
1 |
| #37 |
John Krupinski |
Bristol-Myers Squibb |
1 |
| #37 |
Michael A. Arnold |
Ptc Therapeutics |
1 |
| #37 |
Christopher G. Levins |
MIT |
1 |
| #37 |
John Clayton Webster |
Cbs Interactive |
1 |